Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

New Analyst Forecast: $BBIO Given $96 Price Target

None

We just received data on a new analyst forecast for $BBIO. Sean Laaman from Morgan Stanley set a price target of 96.0 for BBIO.

To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.

Should you buy $BBIO?

Some analysts are better than others. To view the past performance of Morgan Stanley, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.

$BBIO Price Targets

Multiple analysts have issued price targets for $BBIO recently. We have seen 17 analysts offer price targets for $BBIO in the last 6 months, with a median target of $84.0.

Here are some recent targets:

  • Sean Laaman from Morgan Stanley set a target price of $96.0 on 01/06/2026
  • Mani Foroohar from Leerink Partners set a target price of $86.0 on 12/15/2025
  • William Pickering from Bernstein set a target price of $94.0 on 12/11/2025
  • Derek Archila from Wells Fargo set a target price of $84.0 on 11/11/2025
  • Anupam Rama from JP Morgan set a target price of $77.0 on 11/07/2025
  • Raghuram Selvaraju from HC Wainwright & Co. set a target price of $90.0 on 11/03/2025
  • Paul Choi from Goldman Sachs set a target price of $100.0 on 10/31/2025

$BBIO Insider Trading Activity

BBIO Insider Trades

$BBIO insiders have traded $BBIO stock on the open market 79 times in the past 6 months. Of those trades, 0 have been purchases and 79 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:

  • NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 53 sales selling 482,323 shares for an estimated $28,356,866.
  • FRANK MCCORMICK has made 0 purchases and 7 sales selling 274,000 shares for an estimated $17,246,736.
  • CHARLES J HOMCY has made 0 purchases and 3 sales selling 300,000 shares for an estimated $13,912,442.
  • ANDREW LO has made 0 purchases and 4 sales selling 95,599 shares for an estimated $6,319,662.
  • THOMAS TRIMARCHI (President and CFO) has made 0 purchases and 5 sales selling 76,524 shares for an estimated $4,087,207.
  • RONALD J DANIELS sold 61,031 shares for an estimated $3,888,999
  • HANNAH VALANTINE sold 25,484 shares for an estimated $1,683,727
  • ANDREA ELLIS sold 17,167 shares for an estimated $841,183
  • RANDAL W. SCOTT has made 0 purchases and 2 sales selling 10,000 shares for an estimated $666,465.
  • MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $193,960.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BBIO Congressional Stock Trading

Members of Congress have traded $BBIO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BBIO Hedge Fund Activity

We have seen 217 institutional investors add shares of $BBIO stock to their portfolio, and 169 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles